Ozempic, an FDA-approved treatment for type 2 diabetes, blew up when people began using it as a weight loss drug. Since then, various medical studies have found that the key ingredient, semaglutide, has helped people suffering from kidney health, heart health, drug addiction and Alzheimer’s disease.

But new research is showing some negative side effects of the drug, including muscle loss.

An international team published a study in The Lancet medical journal this month with preliminary results that show slightly higher rates of non-fat tissue loss compared to weight loss from means other than prescription drugs.

More here >